Clinical Trial

Helping Young People With Testicular Cancer Using Virtual and Extended Reality

Study acronym: TRANSCEND-XR
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
TRANSCEND-XR is a European research project designed to better support adolescents and young adults who have been cured of testicular cancer. Even after treatment has ended, many young people continue to face physical, psychological, or social difficulties that are often poorly understood and insufficiently addressed. The project aims to develop an innovative digital tool using extended reality (XR) to help these young people better understand the potential long-term effects of the disease and its treatments, recognize signs that require medical attention, and become more active participants in their own health follow-up. TRANSCEND-XR first includes a pilot phase to test feasibility and improve the tool, followed by a larger clinical study comparing its use with usual medical follow-up. Researchers will assess, in particular, its impact on patients' knowledge, quality of life, and ability to seek help. The ultimate goal is to sustainably improve information, autonomy, and well-being among young survivors of testicular cancer through a digital approach tailored to their needs and daily practices.
Trial Details
NCT Number NCT07571499
Lead Sponsor Gustave Roussy, Cancer Campus, Grand Paris
Conditions Testicular Cancer, Testis Cancer, AYA Cancer Survivors, Survivor Patients
Enrollment 245 participants
Start Date 2027-01-04
Primary Completion 2027-06-30 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-06